查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1762497

高雪氏症治療的全球市場:市場規模·佔有率·趨勢，產業分析 (類別·各治療法·各流通管道·各地區)，未來預測 (2025年～2034年)

Gaucher Disease Treatment Market Size, Share, Trends, & Industry Analysis Report: By Type (Type 1, Type 3, Type 2), By Therapy, By Distribution Channel, and By Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 129 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，預計到 2034 年，全球戈謝氏症治療市場規模將達到 21 億美元。本報告深入分析了當前的市場動態，並分析了未來的市場成長。

戈謝氏症是最常見的脂質體貯積症之一，由葡萄糖腦苷脂酶（一種分解脂肪化合物，尤其是葡萄糖腦苷脂的酵素）缺乏所引起。這種酵素缺乏會促使葡萄糖腦苷脂積聚，進而促使脾臟、肝臟和骨髓中形成戈謝細胞。此疾病的主要症狀包括脾臟和肝臟腫大、疲勞、貧血、骨骼不適和骨折以及出血等。

隨著人們對戈謝氏症（一種罕見遺傳性疾病）認識的提高，其診斷和治療也正在不斷進步。認識的提高使更多人能夠獲得早期診斷，從而改善了疾病管理。宣傳活動、強化篩檢以及加強對醫務人員的培訓都促進了這一進步。此外，在高發生率地區擴大並優先開展新生兒篩檢項目，顯著提高了早期發現和及時治療的效果。

美國食品藥物管理局 (FDA) 批准的藥品數量不斷增加，也推動了戈謝氏症治療市場的發展，鼓勵主要市場參與者在藥物開發中採用創新策略。此外，生物製藥公司與研究機構之間的合作預計將在未來幾年推動市場成長。

戈謝氏症治療市場的競爭凸顯了領先公司不斷尋求開發新穎、更有效的治療方法。各公司正專注於探索治療方法的進步和現有治療方法的替代方案，以滿足日益增長的改善患者預後的需求。

戈謝氏症治療市場：分析概述

依治療方法劃分，酵素替代療法佔據市場主導地位，2024 年的收入佔有率為 67.9%。

按類型劃分，戈謝病最常見的類型 1 型，由於患者數量的增加，在 2024 年以 75% 的收入佔有率領先市場。

由於人們對戈謝氏症的認識不斷提高、醫療基礎設施不斷加強以及藥物研發活動不斷活躍，北美在 2024 年以 47.4% 的收入佔有率佔據全球市場主導地位。

預計亞太地區將在預測期內實現最快成長。該地區強勁的成長歸功於醫療基礎設施的改善以及政府為提高人們對罕見和危及生命的疾病的認識而採取的舉措。

戈謝氏症治療市場的主要參與者包括輝瑞公司、楊森製藥公司、JCR製藥公司、賽諾菲健贊、武田製藥有限公司、強生服務公司、Shire Human Genetics Therapeutics, Inc. 和 Elad Therapeutics。

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球高雪氏症治療市場洞察

  • 市場概述
  • 高雪氏症治療的市場動態
    • 促進因素和機會
      • 醫療成本上漲
      • 加強策略合作、收購與夥伴關係
    • 阻礙因素與課題
      • 初始製造成本上升
  • 大環境分析
  • 高雪氏症治療市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球高雪氏症治療市場:類別

  • 主要的分析結果
  • 簡介
  • 第一型
  • 3型
  • 2型

第6章 全球高雪氏症治療市場:各治療法

  • 主要的分析結果
  • 簡介
  • 酵素補充療法(ERT)
  • 基材還原療法(SRT)
  • 其他

第7章 全球高雪氏症治療市場:各流通管道

  • 主要的分析結果
  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第8章 全球高雪氏症治療市場:各地區

  • 主要的分析結果
  • 簡介
    • 高雪氏症治療市場分析:各地區 (2020～2034年)
  • 北美
    • 北美:類別(2020～2034年)
    • 北美:各治療法(2020～2034年)
    • 北美:各流通管道(2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:類別(2020～2034年)
    • 歐洲:各治療法(2020～2034年)
    • 歐洲:各流通管道(2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:類別(2020～2034年)
    • 亞太地區:各治療法(2020～2034年)
    • 亞太地區:各流通管道(2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:類別(2020～2034年)
    • 中東·非洲:各治療法(2020～2034年)
    • 中東·非洲:各流通管道(2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:類別，2020-2034年
    • 南美:各治療法(2020～2034年)
    • 南美:各流通管道(2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第9章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第10章 企業簡介

  • Amicus Therapeutics, Inc.
  • CANbridge Life Sciences Ltd.
  • Eli Lilly and Company
  • Johnson & Johnson, Inc.
  • Lingyi Biotechnology
  • Protalix Biotherapeutics Inc.
  • Sanofi
  • Spur Therapeutics
  • Takeda Pharmaceutical
Product Code: PM1514

The global Gaucher disease treatment market size is expected to reach USD 2.10 billion by 2034, according to a new study by Polaris Market Research. The report "Gaucher Disease Treatment Market Size, Share, Trends, Industry Analysis Report: By Therapy (Substrate Replacement Therapy, Enzyme Replacement Therapy, and Others), Type, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Gaucher disease is one of the most common liposomal storage disorders, caused by a deficiency of glucocerebrosidase, an enzyme responsible for breaking down fatty compounds, specifically glucocerebroside. This enzyme deficiency leads to the accumulation of glucocerebroside, resulting in the formation of Gaucher cells in the spleen, liver, and bone marrow. This condition is primarily characterized by symptoms such as an enlarged spleen or liver, fatigue, anemia, bone discomfort and fractures, and bleeding.

The diagnosis and treatment of Gaucher disease, a rare genetic disorder, are evolving due to increasing awareness of the condition. With greater awareness, more individuals are receiving earlier diagnoses, leading to improved disease management. Awareness campaigns, enhanced screening initiatives, and increased training for healthcare professionals support this progress. Additionally, the expansion and prioritization of newborn screening programs in regions with higher prevalence are significantly improving early identification and timely treatment.

The Gaucher disease treatment market is also driven by an increasing number of drug approvals from the US Food and Drug Administration (FDA), encouraging leading market players to adopt innovative strategies in drug development. Additionally, collaborations between biopharmaceutical and research institutions are expected to accelerate market growth in the coming years.

The competitive nature of the Gaucher disease treatment market highlights that leading players are constantly seeking to develop more novel and effective treatment alternatives. Companies are focused on advancing medical therapies and exploring alternatives to existing treatments, aiming to meet the growing demand for improved patient outcomes.

Key Highlights of Gaucher Disease Treatment Market Report

Based on therapy, the enzyme replacement therapy segment dominated the market with a 67.9% revenue share in 2024, driven by the high number of FDA-approved medications for the therapy.

By type, the Type 1 segment led the market with a 75% revenue share in 2024 due to a rise in patient occurrence, as this is the most commonly occurring type of Gaucher's disease.

North America dominated the global market with a 47.4% revenue share in 2024, driven by greater awareness of Gaucher disease, enhanced healthcare infrastructure, and increasing drug discovery and research activities.

Asia Pacific is expected to register the fastest growth during the forecast period. The region's robust growth is attributed to improved healthcare infrastructure and government efforts to raise awareness about rare and life-threatening diseases.

Key players in the Gaucher disease treatment market include Pfizer Inc.; Janssen Pharmaceuticals; JCR Pharmaceuticals Co Ltd.; Sanofi Genzyme; Takeda Pharmaceuticals; Johnson & Johnson Services, Inc.; Shire Human Genetics Therapies, Inc.; Erad Therapeutic Inc.; and ERAD Therapeutics.

Polaris Market Research has segmented the Gaucher disease treatment market report on the basis of therapy, type, and region:

Gaucher Disease Treatment Market Segmentation

By Therapy Outlook (Revenue - USD Billion, 2020-2034)

Substrate Replacement Therapy

Enzyme Replacement Therapy

Others

By Type Outlook (Revenue - USD Billion, 2020-2034)

Type 1

Type 2

Type 3

Others

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of the Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Gaucher Disease Treatment Market Report Scope

Report Attributes

Details

Market Size Value in 2024

USD 1.64 billion

Market Size Value in 2025

USD 1.67 billion

Revenue Forecast by 2034

USD 2.10 billion

CAGR

  • 2.54% from 2025 to 2034

Base Year

2024

Historical Data

2020-2023

Forecast Period

2025-2034

Quantitative Units

Revenue in USD billion and CAGR from 2025 to 2034

Report Coverage

Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends

Segments Covered

By Therapy

By Type

Regional Scope

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Competitive Landscape

Gaucher Disease Treatment Industry Trends Analysis (2024)

Company profiles/industry participants profiling includes company overview, financial information, product/service benchmarking, and recent developments

Report Format

PDF + Excel

Customization

Report customization as per your requirements with respect to countries, regions, and segmentation.

For Specific Research Requirements

Request for Customized Report

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Gaucher Disease Treatment Market Insights

  • 4.1. Gaucher Disease Treatment Market - Market Snapshot
  • 4.2. Gaucher Disease Treatment Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Healthcare Spending
      • 4.2.1.2. Increasing Strategic Collaboration, Acquisition, and Partnership
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Initial Cost of Manufacturing
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Gaucher Disease Treatment Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Gaucher Disease Treatment Market, by Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • 5.3. Type 1
    • 5.3.1. Global Gaucher Disease Treatment Market, by Type 1, by Region, 2020-2034 (USD Billion)
  • 5.4. Type 3
    • 5.4.1. Global Gaucher Disease Treatment Market, by Type 3, by Region, 2020-2034 (USD Billion)
  • 5.5. Type 2
    • 5.5.1. Global Gaucher Disease Treatment Market, by Type 2, by Region, 2020-2034 (USD Billion)

6. Global Gaucher Disease Treatment Market, by Therapy

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • 6.3. Enzyme Replacement Therapy (ERT)
    • 6.3.1. Global Gaucher Disease Treatment Market, by Enzyme Replacement Therapy (ERT), by Region, 2020-2034 (USD Billion)
  • 6.4. Substrate Reduction Therapy (SRT)
    • 6.4.1. Global Gaucher Disease Treatment Market, by Substrate Reduction Therapy (SRT), by Region, 2020-2034 (USD Billion)
  • 6.5. Others
    • 6.5.1. Global Gaucher Disease Treatment Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Gaucher Disease Treatment Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 7.3. Hospital Pharmacies
    • 7.3.1. Global Gaucher Disease Treatment Market, by Hospital Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Gaucher Disease Treatment Market, by Retail Pharmacies, by Region, 2020-2034 (USD Billion)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Gaucher Disease Treatment Market, by Online Pharmacies, by Region, 2020-2034 (USD Billion)

8. Global Gaucher Disease Treatment Market, by Geography

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 8.3. Gaucher Disease Treatment Market - North America
    • 8.3.1. North America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.3.2. North America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.3.3. North America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.4. Gaucher Disease Treatment Market - U.S.
      • 8.3.4.1. U.S.: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.3.4.2. U.S.: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.4.3. U.S.: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.3.5. Gaucher Disease Treatment Market - Canada
      • 8.3.5.1. Canada: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.3.5.2. Canada: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.3.5.3. Canada: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.4. Gaucher Disease Treatment Market - Europe
    • 8.4.1. Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.4.2. Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.4.3. Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.4. Gaucher Disease Treatment Market - UK
      • 8.4.4.1. UK: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.4.2. UK: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.4.3. UK: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.5. Gaucher Disease Treatment Market - France
      • 8.4.5.1. France: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.5.2. France: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.5.3. France: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.6. Gaucher Disease Treatment Market - Germany
      • 8.4.6.1. Germany: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.6.2. Germany: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.6.3. Germany: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.7. Gaucher Disease Treatment Market - Italy
      • 8.4.7.1. Italy: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.7.2. Italy: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.7.3. Italy: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.8. Gaucher Disease Treatment Market - Spain
      • 8.4.8.1. Spain: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.8.2. Spain: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.8.3. Spain: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.9. Gaucher Disease Treatment Market - Netherlands
      • 8.4.9.1. Netherlands: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.9.2. Netherlands: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.9.3. Netherlands: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.10. Gaucher Disease Treatment Market - Russia
      • 8.4.10.1. Russia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.10.2. Russia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.10.3. Russia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.4.11. Gaucher Disease Treatment Market - Rest of Europe
      • 8.4.11.1. Rest of Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.4.11.2. Rest of Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.4.11.3. Rest of Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.5. Gaucher Disease Treatment Market - Asia Pacific
    • 8.5.1. Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.5.2. Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.5.3. Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.4. Gaucher Disease Treatment Market - China
      • 8.5.4.1. China: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.4.2. China: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.4.3. China: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.5. Gaucher Disease Treatment Market - India
      • 8.5.5.1. India: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.5.2. India: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.5.3. India: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.6. Gaucher Disease Treatment Market - Malaysia
      • 8.5.6.1. Malaysia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.6.2. Malaysia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.6.3. Malaysia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.7. Gaucher Disease Treatment Market - Japan
      • 8.5.7.1. Japan: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.7.2. Japan: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.7.3. Japan: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.8. Gaucher Disease Treatment Market - Indonesia
      • 8.5.8.1. Indonesia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.8.2. Indonesia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.8.3. Indonesia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.9. Gaucher Disease Treatment Market - South Korea
      • 8.5.9.1. South Korea: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.9.2. South Korea: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.9.3. South Korea: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.10. Gaucher Disease Treatment Market - Australia
      • 8.5.10.1. Australia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.10.2. Australia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.10.3. Australia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.5.11. Gaucher Disease Treatment Market - Rest of Asia Pacific
      • 8.5.11.1. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.5.11.2. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.5.11.3. Rest of Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.6. Gaucher Disease Treatment Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.6.2. Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.6.3. Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.4. Gaucher Disease Treatment Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.4.2. Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.4.3. Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.5. Gaucher Disease Treatment Market - UAE
      • 8.6.5.1. UAE: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.5.2. UAE: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.5.3. UAE: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.6. Gaucher Disease Treatment Market - Israel
      • 8.6.6.1. Israel: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.6.2. Israel: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.6.3. Israel: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.7. Gaucher Disease Treatment Market - South Africa
      • 8.6.7.1. South Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.7.2. South Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.7.3. South Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.6.8. Gaucher Disease Treatment Market - Rest of Middle East & Africa
      • 8.6.8.1. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.6.8.2. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.6.8.3. Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • 8.7. Gaucher Disease Treatment Market - Latin America
    • 8.7.1. Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
    • 8.7.2. Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
    • 8.7.3. Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.4. Gaucher Disease Treatment Market - Mexico
      • 8.7.4.1. Mexico: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.4.2. Mexico: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.4.3. Mexico: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.5. Gaucher Disease Treatment Market - Brazil
      • 8.7.5.1. Brazil: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.5.2. Brazil: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.5.3. Brazil: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.6. Gaucher Disease Treatment Market - Argentina
      • 8.7.6.1. Argentina: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.6.2. Argentina: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.6.3. Argentina: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
    • 8.7.7. Gaucher Disease Treatment Market - Rest of Latin America
      • 8.7.7.1. Rest of Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
      • 8.7.7.2. Rest of Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
      • 8.7.7.3. Rest of Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. Amicus Therapeutics, Inc.
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. CANbridge Life Sciences Ltd.
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Eli Lilly and Company
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Johnson & Johnson, Inc.
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. Lingyi Biotechnology
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Protalix Biotherapeutics Inc.
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Sanofi
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Spur Therapeutics
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Takeda Pharmaceutical
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development

List of Tables:

  • Table 1 Global Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 2 Global Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 3 Global Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 4 North America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 5 North America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 6 North America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 7 U.S.: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 8 U.S.: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 9 U.S.: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 10 Canada: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 11 Canada: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 12 Canada: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 13 Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 14 Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 15 Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 16 UK: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 17 UK: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 18 UK: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 19 France: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 20 France: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 21 France: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 22 Germany: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 23 Germany: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 24 Germany: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 25 Italy: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 26 Italy: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 27 Italy: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 28 Spain: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 29 Spain: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 30 Spain: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 31 Netherlands: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 32 Netherlands: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 33 Netherlands: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 34 Russia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 35 Russia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 36 Russia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 37 Rest of Europe: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 38 Rest of Europe: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 39 Rest of Europe: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 40 Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 41 Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 42 Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 43 China: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 44 China: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 45 China: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 46 India: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 47 India: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 48 India: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 49 Malaysia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 50 Malaysia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 51 Malaysia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 52 Japan: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 53 Japan: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 54 Japan: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 55 Indonesia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 56 Indonesia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 57 Indonesia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 58 South Korea: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 59 South Korea: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 60 South Korea: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 61 Australia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 62 Australia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 63 Australia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 64 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 65 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 66 Rest of Asia Pacific: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 67 Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 68 Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 69 Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 70 Saudi Arabia: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 71 Saudi Arabia: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 72 Saudi Arabia: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 73 UAE: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 74 UAE: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 75 UAE: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 76 Israel: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 77 Israel: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 78 Israel: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 79 South Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 80 South Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 81 South Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 82 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 83 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 84 Rest of Middle East & Africa: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 85 Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 86 Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 87 Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 88 Mexico: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 89 Mexico: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 90 Mexico: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 91 Brazil: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 92 Brazil: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 93 Brazil: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 94 Argentina: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 95 Argentina: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 96 Argentina: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)
  • Table 97 Rest of Latin America: Gaucher Disease Treatment Market, by Type, 2020-2034 (USD Billion)
  • Table 98 Rest of Latin America: Gaucher Disease Treatment Market, by Therapy, 2020-2034 (USD Billion)
  • Table 99 Rest of Latin America: Gaucher Disease Treatment Market, by Distribution Channel, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Gaucher Disease Treatment Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Type
  • Figure 7. Global Gaucher Disease Treatment Market, by Type, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Therapy
  • Figure 9. Global Gaucher Disease Treatment Market, by Therapy, 2024 & 2034 (USD Billion)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Gaucher Disease Treatment Market, by Distribution Channel, 2024 & 2034 (USD Billion)
  • Figure 12. Global Gaucher Disease Treatment Market Assessment, By Geography, 2020-2034 (USD Billion)
  • Figure 13. Strategic Analysis - Global Gaucher Disease Treatment Market